Clinical Perspectives of Statin-Induced Rhabdomyolysis

This publication has 96 references indexed in Scilit:

• Striated Muscle Safety of Ezetimibe/Simvastatin (Vytorin)
  The American Journal of Cardiology, 2006
• Changes in Ubiquitin Proteasome Pathway Gene Expression in Skeletal Muscle With Exercise and Statins
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment
  Clinical Pharmacology & Therapeutics, 2005
• The Issue of Statin Safety
  Circulation, 2005
• Not all statins are alike: induced rhabdomyolysis on changing from one statin to another one
  International Journal of Cardiology, 2005
• Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin
  The American Journal of Cardiology, 2005
• Simvastatin Does Not Have a Clinically Significant Pharmacokinetic Interaction With Fenofibrate in Humans
  The Journal of Clinical Pharmacology, 2004
• ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
  Stroke, 2002
• HMG CoA Reductase Inhibitor-Induced Myotoxicity: Pravastatin and Lovastatin Inhibit the Geranylgeranylation of Low-Molecular-Weight Proteins in Neonatal Rat Muscle Cell Culture
  Toxicology and Applied Pharmacology, 1997
• Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in Humans
  The Journal of Clinical Pharmacology, 1992